Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
46.53
+0.27 (0.58%)
Aug 5, 2026, 2:32 PM EDT - Market open
Spruce Biosciences Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Spruce Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $151. The average 1-year stock price forecast is 224.52% higher than the current stock price, while the lowest is $120 (+157.90%) and the highest is $230 (+394.30%).
Price Target: $151 (+224.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Spruce Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 6 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Initiates $160 | Buy | Initiates | $160 | +243.86% | Jul 13, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $123 | Buy | Initiates | $123 | +164.35% | Jun 16, 2026 |
| JonesTrading | JonesTrading | Buy Initiates $135 | Buy | Initiates | $135 | +190.14% | Jun 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $200 → $150 | Buy | Reiterates | $200 → $150 | +222.37% | Jun 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $283 → $230 | Buy | Reiterates | $283 → $230 | +394.30% | May 27, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
86.41M
EPS This Year
-24.89
from -50.83
EPS Next Year
7.38
from -24.89
EPS and Forward PE are based on non-GAAP adjusted numbers.